LIMINATUS PHARMA INC-CL A (LIMN) Stock Balance Sheet
USA - NASDAQ:LIMN - US53271X1081 - Common Stock
1.73 USD
-0.23 (-11.73%)
1.73 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 65.30K | 156.40K | 280.60K | 300.00K | N/A | |||
| Receivables | 6.50K | 54.50K | 1.30K | 0.00 | N/A | |||
| Other Current Assets | 740.90K | 0.00 | 78.80K | 100.00K | 300.00K | |||
| Total Current Assets | 812.70K | 210.90K | 360.70K | 400.00K | 300.00K | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 2.02M | 4.29M | 15.13M | 276.00M | N/A | |||
| Total Non-Current Assets | 2.02M | 4.29M | 15.13M | 276.00M | 0.00 | |||
| TOTAL ASSETS | 2.83M | 4.50M | 15.49M | 276.40M | 300.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 5.12M | 2.27M | 1.04M | 0.00 | 0.00 | |||
| Accrued Expenses | 129.00K | 433.60K | 447.10K | 200.00K | 300.00K | |||
| Accounts Payable | 2.61M | 2.00M | 1.49M | 1.10M | N/A | |||
| Other Current Liabilities | 817.10K | 457.20K | 614.80K | 100.00K | N/A | |||
| Total Current Liabilities | 8.68M | 5.16M | 3.59M | 1.40M | 300.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | N/A | N/A | |||
| Other Non-Current Liabilities | 10.02M | 10.04M | 10.60M | 20.20M | N/A | |||
| Total Non-Current Liabilities | 10.02M | 10.04M | 10.60M | 20.20M | 0.00 | |||
| TOTAL LIABILITIES | 18.70M | 15.20M | 14.19M | 21.60M | 300.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -17.68M | -14.88M | -13.97M | -21.10M | 0.00 | |||
| Additional Paid In Capital | 51.80K | 140.00K | 140.00K | 0.00 | 0.00 | |||
| Common Shares | 1.76M | 4.05M | 15.13M | 276.00M | 0.00 | |||
| Shares Outstanding | 7.07M | 7.31M | 8.31M | 34.50M | 30.00M | |||
| Tangible Book Value per Share | -2.24 | -1.46 | 0.16 | 7.39 | 0.00 | |||
| Total Shareholders' Equity | -15.87M | -10.69M | 1.29M | 254.90M | 0.00 | |||
| TOTAL LIABILITIES AND EQUITY | 2.83M | 4.50M | 15.49M | 276.40M | 300.00K | |||
| Statistics | ||||||||
| Current Ratio | 0.09 | 0.04 | 0.10 | 0.29 | 1.00 | |||
| Return On Assets (ROA) | -102.67% | -27.24% | 66.17% | 1.58% | N/A | |||
| Return On Equity (ROE) | N/A | N/A | 791.94% | 1.71% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21